Nasdaq: LGND
Ligand Pharmaceuticals insiders
The officers, directors and 10% owners of Ligand Pharmaceuticals Incorporated who hold the most stock, valued at the live LGND price.
$286.94
LGND today −$11.8M (−3.94%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 12
- Their LGND stock
- $369M
- Market value
- $5.74B
- Held by ranked insiders
- 6.42%
Insiders by value of LGND holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | John L. Higgins | Director | 417,695 | $120M | 2.09% | 1162nd |
| 2 | Matthew W. Foehr | Insider | 259,986 | $74.6M | 1.30% | 1495th |
| 3 | Todd C. Davis | Chief Executive Officer | 199,513 | $57.2M | 1.00% | 1694th |
| 4 | Jason Aryeh | Director | 110,501 | $31.7M | 0.55% | 3496th |
| 5 | Matthew E. Korenberg | President & COO | 50,777 | $14.6M | 0.25% | 6391st |
| 6 | Sunil Patel | Insider | 46,198 | $13.3M | 0.23% | 6660th |
| 7 | John W. Kozarich | Director | 42,122 | $12.1M | 0.21% | 7620th |
| 8 | Charles S. Berkman | Insider | 38,191 | $11.0M | 0.19% | 7218th |
| 9 | Stephen L. Sabba | Director | 33,629 | $9.6M | 0.17% | 9016th |
| 10 | Andrew Reardon | CLO & Secretary | 31,854 | $9.1M | 0.16% | 9380th |
| 11 | Octavio Espinoza | Chief Financial Officer | 27,696 | $7.9M | 0.14% | 10427th |
| 12 | John L. Lamattina | Director | 26,969 | $7.7M | 0.13% | 9630th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ligand Pharmaceuticals; see each profile for the filing.